News Quantified

TAK – takeda pharmaceutical company limited american depositary shares (each representing 1/2 of a share of) (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Scilex Holding Company Announces Final Court Approval of a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex's intent to Expand the Label for its FDA-Approved Liquid Colchicine Pro

Takeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual Meeting [Yahoo! Finance]

Takeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual Meeting

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease

Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion [Yahoo! Finance]

Form 6-K TAKEDA PHARMACEUTICAL For: May 09

Form 6-K TAKEDA PHARMACEUTICAL For: May 09

Form 6-K TAKEDA PHARMACEUTICAL For: May 09

Form 6-K TAKEDA PHARMACEUTICAL For: May 09

Form 6-K TAKEDA PHARMACEUTICAL For: May 09

Top News Gainers

3/2 Takeda Receives Positive CHMP Opinion for ALUNBRIG® (brigatinib) as a First-Line Treatment for ALK+ Non-Small Cell Lung Cancer 5.1%

4/6 European Commission Approves Takeda’s ALUNBRIG® (brigatinib) as a First-Line Treatment for ALK+ NSCLC 4.9%

7/31 Takeda Announces FY2019 Key Performance Indicators Aligned with Shareholder Value Creation and Focused on Successful Integration 4.9%

3/4 Takeda Completes Sale of Select OTC and Non-Core Assets to STADA 4.8%

5/17 Canadian Blood Services warns of imminent shortage of take-home immune globulin drug [Toronto Globe and Mail (Ontario, Canada)] 3.1%

2/4 Japan's Takeda forecasts surprise full-year operating profit [Yahoo! Finance News] 3.2%

4/27 Takeda ProThera Collaboration, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha] 3.8%

11/1 Takeda Pharmaceutical Co. Ltd (TKPHF) CEO Christophe Weber on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 3.8%

5/9 Asia Markets: Asian markets mostly gain despite looming U.S. tariff hikes targeting Chinese goods [MarketWatch] 4.1%

4/10 Takeda Pharmaceutical Co Ltd (NYSE: TAK) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $18.00 price target on the stock. 4.1%

Top News Decliners

3/4 Japan stocks track Wall Street higher, but virus worries weigh [Reuters] -2.7%

3/4 Japan's Takeda Pharma says it is developing coronavirus drug [Reuters (UK)] -2.7%

7/9 Takeda Continues Ongoing Inclusion in the FTSE4Good Developed Index & MSCI ESG Leaders Index -3.0%

11/8 New Analyses from the Phase 3 HELP Study™ Open-Label Extension in Hereditary Angioedema Evaluate Efficacy and Safety of TAKHZYRO® (lanadelumab-flyo) Injection During Extended Study Treatment Period -3.6%

5/16 Takeda Pharmaceutical Co Ltd (NYSE: TAK) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -3.6%

11/9 2 Biotech Stocks Fighting Alzheimer’s Disease to Own Now [The Motley Fool] -4.0%

10/21 Retrospective Real-World Comparative Analysis Highlights Safety of Vedolizumab and Anti-TNFa Therapies in Biologic-Naïve Patients with Ulcerative Colitis or Crohn’s Disease -5.0%

2/26 Form POS AM TAKEDA PHARMACEUTICAL -6.6%

5/14 Takeda forecasts operating loss as Shire integration costs mount [FT.com - Mergermarket] -8.0%

3/17 The Lancet publishes papers from two studies of Takeda’s dengue vaccine candidate -10.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day